Exproleterly investigation with using Plenty of MTX treatment following ivtreous injection of MTX in primaly intraoculat lymphoma

Exproleterly investigation with using Plenty of MTX treatment following ivtreous injection of MTX in primaly intraoculat lymphoma - Plenty of MTX treatment following ivtreous injection of MTX in primaly intraoculat lymphoma

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000017340

Enrollment

Registered

2015-05-01

Start date

2014-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primaly intra ocular lymphoma

Interventions

treatment with MTX

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient wiht intraouclatr lymphoma

Exclusion criteria

Exclusion criteria: Pathine wiht poor general status

Design outcomes

Primary

Measure	Time frame
recurrence	—

Countries

Japan

Contacts

Public ContactKazuichi Maruyama

Tohoku University Graudate School of Medicine Ophthalmology

maruyama-k@oph.med.tohoku.ac.jp022-717-7294

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026